Catheter; Infection (Indwelling Catheter), Catheter Infection, Catheter-Related Infections, Catheter Bacteraemia, Urinary Tract Infections
Conditions
Keywords
Catheter associated UTI, Povidine iodine, Bladder Irrigation
Brief summary
Over the last decade, there has been great emphasis on reducing the incidence of hospital-acquired infections, including catheter-associated UTI (CAUTI). This study will evaluate the effectiveness of Betadine irrigation solution (2% povidone-iodine) instilled into the bladder immediately prior to indwelling catheter removal to decrease the risk of subsequent bacteriuria, leading to decreased rates of NHSN defined CAUTI.
Detailed description
Indwelling urinary catheters are routinely used in the care of hospitalized patients for a variety of reasons, including monitoring of urine output in critically ill patients, relief of urinary obstruction, and prevention of contamination of decubitus ulcers. Bacteriuria increases by 3-10% each day a catheter is left in place, meaning that by 30 days, generally 100% of patients with indwelling catheters will have bacteria in their urine. The majority of these people do not have urinary tract infections (UTIs), they are merely colonized and do not require treatment. To define a standard (and ultimately to compare hospitals against each other), a surveillance definition for CAUTI has been developed by the National Healthcare Safety Network (NHSN). While useful for surveillance, the definition does not correlate with clinical UTIs, leading to over diagnosis and over-reporting of UTIs (in other words, those with merely bladder colonization being diagnosed as having a UTI). Despite continuing progress in standard methods of reducing infection rates (including decreasing the number of catheters inserted, ensuring proper catheter maintenance, and removing catheters when no long necessary) there continue to be unacceptably high rates of CAUTIs. A single dose of povidone-iodine prior to catheter removal seems a novel and promising practice for several reasons. First, we suspect it will be helpful in reducing rates of NHSN defined CAUTI, as these are still diagnosed for 2 days after the catheter is removed. Second, using multiple doses of povidone-iodine would be inadvisable, since we suspect bacteria over time would become resistant even to this antiseptic. Third, we suspect use of an antiseptic is preferable to an antibacterial for preventing further antimicrobial resistance development. Finally, use of this method, as opposed to the suggested use of systemic antibiotics at time of removal, is potentially preferable from the downstream standpoint of less antimicrobial resistance and reduced risk of Clostridium difficile infection.
Interventions
Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique
Sponsors
Corewell Health East
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
2 arm parallel study with 1 to 1 randomization
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Provide written informed consent and the willingness and ability to comply with all aspects of study requirements 2. Male 3. Inpatients ≥ 18 years of age with an indwelling catheter in place for at least 5 days with a plan for removal
Exclusion criteria
1. Patients planned for discharge with an indwelling catheter in place 2. Patients unable to report urinary symptoms accurately 3. Patients with hyper-sensitivity or allergic reaction to Betadine, iodine, shellfish or other related compounds 4. Clinical signs or symptoms of urinary tract infection at the time of consent 5. Patients currently being treated for UTI 6. Patients currently taking any antibiotic medication, other than vancomycin, linezolid, daptomycin, clindamycin, or metronidazole. 7. Patients already taking medications known to potentially irritate the bladder, such as, but not limited to, cyclophosphamide, ifosfamide, and other chemotherapeutic agents 8. Patients with history of bladder cancer, pelvic radiation or interstitial cystitis 9. Patients unable to comply with study requirements 10. Any other condition which, per investigators' judgment, may increase patient risk and/or impede the reliability of study data
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diagnosis of Urinary Tract Infection (UTI) | 48-72 hours after catheter removal | Per NHSN defined catheter associated UTI (CAUTI) criteria |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Diagnosis of UTI at 7 Days | 7 days after catheter removal | Per National Healthcare Safety Network (NHSN) defined CAUTI criteria |
| Diagnosis of UTI at 28 Days | 28 days after catheter removal | Per NHSN defined CAUTI criteria |
Countries
United States
Participant flow
Recruitment details
Patients were recruited from the inpatient units of the hospital.
Participants by arm
| Arm | Count |
|---|---|
| Povidone-Iodine Irrigation Bladder irrigation with 2% povidine-iodine irrigation immediately prior to catheter removal
Povidone-iodine irrigation: Single dose, 60 cc of 2% povidone-iodine indwelling for 10 minutes prior to catheter removal using aseptic technique | 0 |
| Standard of Care Catheter removal with no bladder irrigation | 3 |
| Total | 3 |
Baseline characteristics
| Characteristic | Povidone-Iodine Irrigation | Standard of Care | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 0 Participants | 3 Participants | 3 Participants |
| Presence of urinary tract infection | 0 Participants | 0 Participants | 0 Participants |
| Race and Ethnicity Not Collected | — | — | 0 Participants |
| Region of Enrollment United States | 0 Participants | 3 Participants | 3 Participants |
| Sex: Female, Male Female | 0 Participants | 0 Participants | 0 Participants |
| Sex: Female, Male Male | 0 Participants | 3 Participants | 3 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 3 |
| other Total, other adverse events | 0 / 0 | 0 / 3 |
| serious Total, serious adverse events | 0 / 0 | 0 / 3 |
Outcome results
Primary
Diagnosis of Urinary Tract Infection (UTI)
Per NHSN defined catheter associated UTI (CAUTI) criteria
Time frame: 48-72 hours after catheter removal
Population: Patients with an indwelling catheter meeting the study eligibility criteria
Secondary
Diagnosis of UTI at 28 Days
Per NHSN defined CAUTI criteria
Time frame: 28 days after catheter removal
Population: Study terminated due to low enrollment
Secondary
Diagnosis of UTI at 7 Days
Per National Healthcare Safety Network (NHSN) defined CAUTI criteria
Time frame: 7 days after catheter removal
Population: Study terminated due to low enrollment